Abbott Laboratories’ stock ABT rose 1.6% in premarket trade Thursday, after the diagnostics and medical-device company posted earnings that were lower than a year ago but ahead of analyst estimates. The company had net income of $1.375 billion, or 78 cents a share, for the quarter, down from $2.018 billion, or $1.14 a share, in the year-earlier period. Adjusted per-share earnings came to $1.08, ahead of the $1.05 FactSet consensus. Sales fell 11.4% to $9.
6% in premarket trade Thursday, after the diagnostics and medical-device company posted earnings that were lower than a year ago but ahead of analyst estimates. The company had net income of $1.375 billion, or 78 cents a share, for the quarter, down from $2.018 billion, or $1.14 a share, in the year-earlier period. Adjusted per-share earnings came to $1.08, ahead of the $1.05 FactSet consensus. Sales fell 11.4% to $9.978 billion, but were also ahead of the $9.972 billion FactSet consensus.